Dr. Basu Ray research interest includes interventional therapies for cardiac disorders like A trial Fibrillation and Ventricular Tachycardia. His work has been published in leading technical cardiology and cardiac electrophysiology journals.
His present interest is studying the role of meditation on human body under physiological and pathological states. He delivers lectures and conducts workshop on meditation and how it can be used to prevent diseases like heart attacks, cancers and other immunological conditions.
The differentiation of the use of multimodality imaging of the hibernating myocardium from scar tissue and the visualization of the effects of revascularization on myocardium with different amounts of scar tissue and hibernation. This anatomically delineates the circuits for ventricular tachycardia and fibrillation for isolation and ablation and prevention of VT, VF and SCD. Both dog and sheep models of myocardial infarction are used for the imaging.
Determination of the parameters that define VT initiation and maintenance after successful revascularization, including patient profile, cardiac risk, myocardium in jeopardy, comparison of MRI/CT/Echo/NST based viable myocardium.
Atrial fibrillation remains the most common arrhythmia in practice and stroke is one of the main killers and cause for morbidity worldwide. This current research garners the newly acquired knowledge of LAA morphology to determine the factors that induce thrombus formation in patients with atrial fibrillation leading to stroke.
Includes research involving brain imaging, hormonal changes, immunological parameters in various states of consciousness and heart disease. Coronary artery disease is the most common killer in the Western Hemisphere. Factors studied include the role of emotions and environmental changes, including adverse environment, in precipitating and sustaining heart diseases. These include the role of meditation, stress reduction and biofeedback on the mind-heart axis to prevent and treat cardiovascular pathology initiated in a stressed organism.
Chief Research Mentor & Assistant Program Director Internal Medicine Residency Program & Member, Cardiology Research Board, Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine.
Instructor in Medicine, Division of Cardiology: In-charge of the Experimental EP Lab, Beth Israel Deaconess Medical Center.
The direction of the cardiovascular electrophysiology research lab involved research that spanned the use of animal models to delineate hibernating myocardium from dead myocardium and the clinical effects of revascularization. Different imaging modalities were used in sync, including MRI, voltage mapping, CT & nuclear imaging to detect living myocardium in chronic total occlusion. This research also investigated the effects of revascularization on myocardium with different amounts of scar tissue and hibernation. This involved the creation of a new sheep model of hibernating myocardium that is particularly useful for such studies, unlike the existing pig model. Additionally, the validation of the use of fractional QRS to determine myocardial viability for CTO was investigated. Both heart failure and ischemia models for the determination of the etiology of VT were created to see if they were amenable to revascularization or drug therapy.